HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lactic acidosis incidence with metformin in patients with type 2 diabetes and chronic kidney disease: A retrospective nested case-control study.

AbstractObjective:
Compare rates of lactic acidosis (LA) among metformin-exposed and unexposed patients with type 2 diabetes mellitus and varying degrees of chronic kidney disease (CKD).
Research Design and Methods:
Retrospective, nested case-control study using data from national VA Corporate Data Warehouse. All adult patients with type 2 diabetes and CKD newly dispensed any antihyperglycaemic medication during FY 2003-13 were included. The outcome was LA hospitalization or serum lactate >5 mEq/L. Exposure to metformin was evaluated in the three months prior to event. Estimates were adjusted for 31 covariates, including demographics, comorbidities and medications.
Results:
Overall, 320 882 patients were included, contributing a total of 1 331 784 person-years of follow-up. LA occurred in 2 665 patients, generating an overall incidence rate of 2.00 (95% CI 1.93-2.08) per 1000 person-years. Metformin exposure in the prior 3 months was associated with an elevated adjusted hazard of LA (HR 1.97, 95% CI 1.69-2.29). No association was evident in patients with CKD stage 1 or 2 (HR 1.05, 95% CI 0.71-1.57), but associations were present and progressively greater in patients with CKD stage 3a through 5: HR 3.09, 95% CI 2.19-4.35 in CKD 3a, HR 3.34, 95% CI 1.95-5.72 in CKD 3b, HR 7.87, 95% CI 3.51-17.61 in CKD stage 4&5.
Conclusion:
Metformin was not associated with an elevated risk of LA in persons with stage 1-2 CKD, but was associated with a progressively higher risk at more advanced stages of CKD.
AuthorsCarlos A Alvarez, Ethan A Halm, Mary Jo V Pugh, Darren K McGuire, Sean Hennessy, Richard T Miller, Ildiko Lingvay, Scott M Vouri, Andrew R Zullo, Hui Yang, Matt Chansard, Eric M Mortensen
JournalEndocrinology, diabetes & metabolism (Endocrinol Diabetes Metab) Vol. 4 Issue 1 Pg. e00170 (01 2021) ISSN: 2398-9238 [Electronic] England
PMID33532612 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)
Copyright© 2020 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.
Chemical References
  • Metformin
Topics
  • Acidosis, Lactic (etiology)
  • Aged
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 (complications, drug therapy)
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Male
  • Metformin (adverse effects)
  • Middle Aged
  • Negative Results
  • Propensity Score
  • Renal Insufficiency, Chronic (complications)
  • Retrospective Studies
  • Risk
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: